Sorry for your loss. Sorry for all those who keep hanging on. I warned earlier in the week that multiple issues face Arch. It appears they have not been able to satisfy the FDA with some basics and how foolish to blame the FDA publicly in this press release. The best outcome imo would be for the board to remove Norchi. He has only paid his outrageous salary all these years and has made little progress to get AC5 to market.
Today's concise and clear step by step plan should answer the underlying questions .....what,when, and how. The process to be employed is presently underway according to the statement "The Company has presented this proposal to the FDA via the pre-submission process with the intention of ensuring that the strategy will address their questions" This seems to be saying that before we go any further, we want to know that the results will satisfy your concerns.
News 
Market Data 
Discover 
AI
